Suppr超能文献

p62 在 5-氟尿嘧啶和奥沙利铂耐药结直肠癌细胞死亡和存活中的作用。

The role of p62 in cell death and survival of 5-fluorouracil and oxaliplatin-resistant colorectal cancer cells.

机构信息

Department of Biochemistry and Molecular Biology, Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius, Lithuania.

出版信息

J Cell Biochem. 2023 Nov;124(11):1779-1791. doi: 10.1002/jcb.30488. Epub 2023 Oct 16.

Abstract

The protein sequestosome 1 (p62/SQSTM1) is primarily known as a selective autophagy cargo receptor, but due to its multidomain structure, it also has roles in the ubiquitin-proteasome system, metabolism, cell death and survival signalling. The increase in p62 levels is detected in some types of cancers, including colorectal cancer (CRC). Chemoresistance is the main cause of high mortality rates of CRC patients. Since p62 can regulate both cell survival and death, it is a potential modulator of chemoresistance. The impact of p62 on molecular causes of chemoresistance in CRC cells is insufficiently analysed. Therefore, we aimed to determine the impact of p62 on apoptosis, RIPK1-pRIPK3 axis, and IL-8 levels in chemoresistant CRC cells. Our data revealed that p62 levels are higher in the 5-fluorouracil (5-FU)-resistant HCT116/FU subline compared to the parental cell line. 5-FU and oxaliplatin (OxaPt) treatment decreased p62 protein levels and it correlated with chemoresistance of HCT116 and DLD1 cell lines. The silencing of p62 increased CRC cell sensitivity to 5-FU and OxaPt, hence p62 is one of the factors supporting chemoresistance. The downregulation of p62 reduced the activation of caspase-3 and the levels of RIPK1 and pRIPK3. Furthermore, p62 silencing decreased the BAX/BCL2 ratio in the HCT116/FU subline and did not change the levels of apoptosis. Instead, p62 silencing reduced the amount of IL-8 protein. Our results show that p62 impacts chemoresistance by stimulating prosurvival signalling.

摘要

蛋白自噬衔接蛋白 1(p62/SQSTM1)主要作为一种选择性自噬货物受体而被熟知,但由于其多结构域的特性,它在泛素蛋白酶体系统、代谢、细胞死亡和存活信号中也具有作用。在包括结直肠癌(CRC)在内的一些癌症类型中,p62 水平增加。化疗耐药性是 CRC 患者高死亡率的主要原因。由于 p62 可以调节细胞的存活和死亡,因此它是化疗耐药性的潜在调节剂。p62 对 CRC 细胞中化疗耐药性的分子原因的影响尚未得到充分分析。因此,我们旨在确定 p62 对化疗耐药性 CRC 细胞凋亡、RIPK1-pRIPK3 轴和 IL-8 水平的影响。我们的数据显示,5-氟尿嘧啶(5-FU)耐药的 HCT116/FU 亚系中的 p62 水平高于亲本细胞系。5-FU 和奥沙利铂(OxaPt)处理降低了 p62 蛋白水平,并且与 HCT116 和 DLD1 细胞系的化疗耐药性相关。p62 的沉默增加了 CRC 细胞对 5-FU 和 OxaPt 的敏感性,因此 p62 是支持化疗耐药性的因素之一。p62 的下调降低了 caspase-3 的激活和 RIPK1 和 pRIPK3 的水平。此外,p62 沉默降低了 HCT116/FU 亚系中 BAX/BCL2 比值,而不改变细胞凋亡水平。相反,p62 沉默减少了 IL-8 蛋白的量。我们的结果表明,p62 通过刺激生存信号来影响化疗耐药性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验